MEOX2 and early-onset autosomal dominant Alzheimer disease: Reduction of MEOX2 expression has been shown in brains of Alzheimer’s disease patients [6], and its haploinsufficiency was reported to lead to neurovascular dysfunction and susceptibility to Amyloid‐β toxicity in Meox2+/− mice [7].